prof. Eva Van Braeckel
- Work address
-
C. Heymanslaan 10, ingang 12 - verdieping 7
9000 Gent - ORCID iD
-
0000-0002-7242-0747
Show
Sort by
-
- Journal Article
- A1
- open access
Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19
-
- Journal Article
- A1
- open access
Safety and efficacy of vanzacaftor–tezacaftor–deutivacaftor in adults with cystic fibrosis : randomised, double-blind, controlled, phase 2 trials
-
- Journal Article
- A1
- open access
EQUAL CPA Score 2022 : a tool to measure guideline adherence for chronic pulmonary aspergillosis
-
- Journal Article
- A1
- open access
Glycemic indices at night measured by CGM are predictive for a lower pulmonary function in adults but not in children with cystic fibrosis
-
- Journal Article
- A1
- open access
Loss of GM-CSF-dependent instruction of alveolar macrophages in COVID-19 provides a rationale for inhaled GM-CSF treatment
-
Factors associated with clinical progression to severe COVID-19 in people with cystic fibrosis : a global observational study
-
Video-assisted thoracic surgery in critically ill COVID-19 patients on venovenous extracorporeal membrane oxygenation
-
- Journal Article
- A2
- open access
Solid medical hospital waste in times of corona : increased volume but no increased biohazard risk
-
- Journal Article
- A1
- open access
Efficacy and safety of the investigational complement C5 inhibitor zilucoplan in patients hospitalized with COVID-19 : an open-label randomized controlled trial
-
- Journal Article
- A1
- open access
Altered intravenous drug disposition in people living with cystic fibrosis : a meta‐analysis integrating top‐down and bottom‐up data